Retracted: Research Article Flavocoxid Protects Against Cadmium-Induced Disruption of the Blood-Testis Barrier and Improves Testicular Damage and Germ Cell Impairment in Mice
Occludin
Cadmium chloride
Malondialdehyde
Reproductive toxicity
DOI:
10.1093/toxsci/kfv185
Publication Date:
2015-10-14T01:38:03Z
AUTHORS (19)
ABSTRACT
Abstract Cadmium (Cd) causes male infertility. There is the need to identify safe treatments counteracting this toxicity. Flavocoxid a flavonoid that induces balanced inhibition of cyclooxygenase (COX)-1 and COX-2 peroxidase moieties 5-lipoxygenase (LOX) has efficacy in genitourinary system. We investigated flavocoxid effects on Cd-induced testicular toxicity mice. Swiss mice were divided into 4 groups: 2 control groups received 0.9% NaCl (vehicle; 1 ml/kg/day) or (20 mg/kg/day ip); challenged with cadmium chloride (CdCl2; ip) administered vehicle flavocoxid. The treatment lasted for weeks. testes processed biochemical morphological studies. CdCl2 increased phosphorylated extracellular signal-regulated kinase (p-ERK) 1/2, tumor necrosis factor (TNF)-α, COX-2, 5-LOX, malondialdehyde (MDA), B-cell-lymphoma (Bcl)-2-associated X protein (Bax), follicle-stimulating hormone (FSH), luteinizing (LH), transforming growth (TGF) -β3, decreased Bcl-2, testosterone, inhibin-B, occludin, N-Cadherin, induced structural damages testis disrupted blood-testis barrier. Many TUNEL-positive germ cells changes claudin-11, N-cadherin localization present. administration reduced, time-dependent way, p-ERK TNF-α, MDA, Bax, FSH, LH, TGF-β3, augmented inhibin B, improved organization Few present retrieval intercellular junctions was observed. In conclusion, protective anti-inflammatory, antioxidant, antiapoptotic function against testis. suggest may play relevant positive role environmental levels Cd, otherwise deleterious gametogenesis tubular integrity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (45)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....